The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma

National Medical Journal of China

Volumn 87, Issue 41, 2007, Pages 2919-2924

  Song, Yue ^a   Shen, Keng ^a   Yu, Jing Rong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Caspase; Ovarian neoplasms; Promoter regions(genetics); Tolomerase

Indexed keywords

ADENOVIRUS VECTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; ENHANCED GREEN FLUORESCENT PROTEIN; EPIDERMAL GROWTH FACTOR; HERPESVIRUS VECTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATE BUFFERED SALINE; PROTEIN P17; PROTEIN P85; TELOMERASE REVERSE TRANSCRIPTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BAGG ALBINO MOUSE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER TISSUE; CATALYSIS; CELL COUNT; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG CYTOTOXICITY; DRUG EFFICACY; ENDOTHELIUM CELL; ENZYME DEGRADATION; ENZYME SUBSTRATE COMPLEX; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER PARENCHYMA; LIVER TOXICITY; MOUSE; NICK END LABELING; NONHUMAN; OVARY CARCINOMA; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SUBCUTANEOUS TISSUE TUMOR; SURVIVAL RATE; SURVIVAL TIME; TISSUE SPECIFICITY; TUMOR VOLUME; UMBILICAL VEIN; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRUSES, HUMAN; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CATALYSIS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; GENE THERAPY; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; OVARIAN NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY; TELOMERASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 38749120078     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Song Y, Kong B, Ma D, et al. Procaspase-3 enhance the in vitro effect of cytosine deaminase-thymidine kinase disuicide gene therapy on human ovarian cancer. Int J Gynecol Cancer, 2006, 16:156-164.
2. Srinivasula SM, Ahmad M, MacFarlane M, et al. Generation of constitutively active recombinant caspase-3 and -6 by rearrangement of their subunits. J Bio Chem, 1998, 273:10107-10111.
3. Lily Y, Zehong C, Hui Y, et al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptotic proteins in human tumor cells: implication for cancer specific therapy. Cancer Res, 2003, 63:6815-6824.
4. Cam L, Boucquev A, Coulomb-L'hemine A, et al. Gene transfer of constitutively active caspase-3 induces apoptosis in a human hepatoma cell line. J Gene Med, 2005, 7:30-38.
5. Wirth T, Kuhnel F, Kubicka S, et al. Telomerase-dependent gene therapy. Curr Mol Med, 2005, 5:243-251.
6. Kagawa S, Gu J, Swisher SG, et al. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. Cancer Res, 2000, 60:1157-1161.
7. Krasnykh VN, Douglas JT, van Beusechem VW. Genetic targeting of adenoviral vectors. Mor Ther, 2000, 1:391-405.
8. Yin J, Fu P, Wang X, et al. Tumor-specific expression detected with the use of an expression vector driven by human telomerase reverse transcriptase gene promoter. J Lab Clin Med, 2004, 144: 302-306.
9. Padmanabhan P, Otero J, Ray P, et al. Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct. J Nucl Med, 2006, 47:270-277.
10. Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res, 1999, 59:551-557.
11. Murofushi Y, Nagano S, Kamizono J, et al. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy. Int J Oncol, 2006, 29: 681-688.
12. Chinese source.
13. Uana B, Orit CB, Catherine S, et al. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Cancer Res, 2001, 61:5529-5536.
14. 0 DNA content. Cytometry, 2000, 39:141-150.